ID   UCRU-BL-23
AC   CVCL_M008
SY   UCRU-BL-23/3; BL-23; BL23; UCRU-BL-17/23alpha; Urological Cancer Research Unit-BLadder-23
DR   Cosmic; 735773
DR   Wikidata; Q54989702
RX   Patent=US5622836;
RX   PubMed=2685375;
RX   PubMed=8635192;
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M007 ! UCRU-BL-17
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 10
//
RX   Patent=US5622836;
RA   Walker K.Z., Russell P.J.;
RT   "Monoclonal antibodies which recognize malignant cells from bladder
RT   carcinomas.";
RL   Patent number US5622836, 22-Apr-1997.
//
RX   PubMed=2685375; DOI=10.1016/S0022-5347(17)39172-3;
RA   Walker K.Z., Russell P.J., Kingsley E.A., Philips J., Raghavan D.;
RT   "Detection of malignant cells in voided urine from patients with
RT   bladder cancer, a novel monoclonal assay.";
RL   J. Urol. 142:1578-1583(1989).
//
RX   PubMed=8635192; DOI=10.1007/BF01526554;
RA   Kingsley E.A., Carter T.E., Barrow K.D., Russell P.J.;
RT   "Characterisation of the anti-bladder-cancer monoclonal antibody
RT   BLCA-8: identification of its antigen as a neutral glycolipid.";
RL   Cancer Immunol. Immunother. 41:348-354(1995).
//